the associations between serum concentrations of irisin and glucose-dependent insulinotropic polypeptide with body mass index among women with and without polycystic ovary syndrome

Background: the actions of adipocytokines may be a connective factor between obesity and polycystic ovary syndrome (pcos). it is suggested that irisin, as recently described cytokine secreted by skeletal muscles and glucose-dependent insulinotropic polypeptide (gip) as an incretin hormone that induces cytokine expression, may play key roles in favoring obesity in these women. objectives:we aimed to evaluate the association between body mass index (bmi) and serum concentrations of irisin/gip in women with and without pcos in the linear and non-linear models. methods: this cross-sectional study was conducted among 159 pcos and 82 healthy eumenorrheic non-hirsute women aged 20 - 50 years. the fractional-polynomial model was used to develop a model of continuous risk factors, which evaluates non-linear associations between irisin/gip and bmi among women with and without pcos. results: women with pcos were significantly younger (28.2±5.8 vs. 33.0±7.8 years, p < 0.001) and had a greater bmi (26.6±5.2 vs. 25.2±4.8 kg/m², p = 0.04) than the healthy counterparts. there were no significant linear and non-linear associations between serum concentration of irisin/gip and bmi in both groups. the analysis of pair-wise age and bmi matching of women with pcos and controls confirmed these findings. conclusions: this study showed that irisin and gip have no association with bmi in women with or without pcos. this finding could help to better understand the underlying pathophysiological status of pcos, insulin resistance, and obesity-related disorders. further large cohort studies are needed to confirm these findings.